Financial statements and notices obtained by Rappler show the controversial supplier Pharmally Pharmaceutical Corporation is poised to earn at least 2 billion more in additional pandemic contracts in 2021.
Full story: https://www.rappler.com/newsbreak/in-depth/pharmally-bags-more-government-deals-2021